Bluebird bio Inc’s recently made public that its Chief Medical Officer Colvin Richard A unloaded Company’s shares for reported $2289.0 on Mar 03 ’25. In the deal valued at $3.92 per share,584 shares were sold. As a result of this transaction, Colvin Richard A now holds 7,610 shares worth roughly $31048.8.
Then, Klima Thomas J sold 500 shares, generating $1,960 in total proceeds. Upon selling the shares at $3.92, the insider now owns 7,878 shares.
Before that, Obenshain Andrew sold 921 shares. Bluebird bio Inc shares valued at $3,610 were divested by the President and CEO at a price of $3.92 per share. As a result of the transaction, Obenshain Andrew now holds 18,327 shares, worth roughly $74774.16.
JP Morgan upgraded its Bluebird bio Inc [BLUE] rating to a Neutral from a an Underweight in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid November from “a Neutral” to “an Underweight”. BofA Securities also remained covering BLUE and has decreased its forecast on November 15, 2024 with a “Neutral” recommendation from previously “Buy” rating. JP Morgan revised its rating on August 15, 2024. It rated BLUE as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of BLUE
On Friday, Bluebird bio Inc [NASDAQ:BLUE] saw its stock jump 7.65% to $4.08. Over the last five days, the stock has gained 4.62%. Bluebird bio Inc shares have fallen nearly -51.08% since the year began. Nevertheless, the stocks have fallen -83.00% over the past one year. While a 52-week high of $28.60 was reached on 01/06/25, a 52-week low of $3.56 was recorded on 02/24/25. SMA at 50 days reached $5.55, while 200 days put it at $11.13.
Levels Of Support And Resistance For BLUE Stock
The 24-hour chart illustrates a support level at 3.72, which if violated will result in even more drops to 3.35. On the upside, there is a resistance level at 4.44. A further resistance level may holdings at 4.79. The Relative Strength Index (RSI) on the 14-day chart is 41.92, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.01, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 44.87%. Stochastics %K at 35.00% indicates the stock is a holding.
How much short interest is there in Bluebird bio Inc?
A steep rise in short interest was recorded in Bluebird bio Inc stocks on 2025-03-14, dropping by -0.87 million shares to a total of 1.85 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 2.72 million shares. There was a decline of -47.21%, which implies that there is a negative sentiment for the stock.
